product

Detection Kits & Sample-prep

Cervical Cancer

This product is used for in vitro qualitative detection of hypermethylation of the gene PCDHGB7 in cervical specimens.
Learn More >>
Endometrial Cancer

This product is used for in vitro qualitative detection of hypermethylation of the gene PCDHGB7 in cervical specimens.
Learn More >>
Urothelial Cancer

This product is used for in vitro qualitative detection of hypermethylation of the Urothelial Carcinoma(UC) gene in urothelial specimens.
Learn More >>
Pan-cancer

The whole-cancer detection is the plasma ctDNA methylation test products that are developed by TAGMe, which requires at least 3ml of whole blood to
Learn More >>

more >>

about us

About Epiprobe

Shanghai Epiprobe Biotechnology Co., Ltd.

what we do

As a high-tech enterprise founded in 2018 by top epigenetic experts, Epiprobe focuses on the molecular diagnosis of cancer DNA methylation and precision theranostics industry. With a profound technology basis, we aim to lead the era of new products to nip cancer in the bud!

Based on Epiprobe core team’s long-term research, development and transformation in the field of DNA methylation with the cutting-edge innovations, combined with the unique DNA methylation targets of cancers, we use a unique multivariate algorithm combining big data and artificial intelligence technology to independently develop an exclusive patent-protected liquid biopsy technology.